Gates Package — page 745

From: Trevor Mundel HR 2 «21s foundation.org> To: "Lane, Cliff (NIH/NIAID) [E]" [@niaid.nih.gov>, "Conrad, Patricia (NIH/NIAID) [E]" BEE 0 niaianin gov> Cc: Christa Bowles HE 6 «21s foundation.or, >. Mike Poole HR 2 «tes foundation.org>, Penny Heaton SS Subject: Re: on behalf of Dr. Fauci Date: Wed, 15 Apr 2020 15:07:47 -0400 Importance: Normal Cliff, that would be great let's target 6:30pm EDT - we'll send a dial in as Mike and Penny will join. Trevor Trevor Mundel, MD, PhD President, Global Health Program V| a E gatesfoundation.org Christa Bowles Executive Assistant Office of the President, Global Health V M EB )gatesfoundation.org Bill & Melinda Gates Foundation www.gatesfoundation.org From: Lane, Cliff (NIH/NIAID) [E] |f@niaid.nih.gov> Sent: Wednesday, April 15, 2020 11:46 AM To: Trevor Mundel; Conrad, Patricia (NIH/NIAID) [E] Cc: Christa Bowles; Mike Poole Subject: Re: on behalf of Dr. Fauci Any time 6 PM EDT or later would work for me. Easiest way is by cell: I From: Trevor Mundel HR © gatesfoundation.org> Date: Wednesday, April 15, 2020 at 2:43 PM To: "Conrad, Patricia (NIH/NIAID) [E]" niaid.nih.gov> : "Lane, Cliff (NIH/NIAID) [E]" niaid.nih.gov>, Christa Bowles HR © gatesfoundation.org>, Ce Mike Poole HE © gatesfoundation.org> Subject: Re: on behalf of Dr. Fauci Thanks Pat, hi Cliff we were just on a call with Tony and Bill and they agreed that we should look at how we might coordinate our activities in the plasma trial space as we are working with the same consortium to see if recruitment of donors and the actual trial might be accelerated. As we're more focused on post-exposure prophylaxis and treatment of mild high risk cases to prevent progression there might be some synergies with your focus. I'm copying in my colleague Mike Poole who is leading our efforts and though we might get together on a call soon. Trevor Trevor Mundel, MD, PhD. President, Global Health Program